Search Results
Search for other papers by W Lei in
Google Scholar
PubMed
Search for other papers by T Hirose in
Google Scholar
PubMed
Search for other papers by L-X Zhang in
Google Scholar
PubMed
Search for other papers by H Adachi in
Google Scholar
PubMed
Search for other papers by M J Spinella in
Google Scholar
PubMed
Search for other papers by E Dmitrovsky in
Google Scholar
PubMed
Search for other papers by A M Jetten in
Google Scholar
PubMed
ABSTRACT
We have cloned a cDNA encoding the full-length coding region of the human homologue of the germ cell nuclear factor (GCNF)/retinoid receptor-related testis-associated receptor (RTR), from a human testis cDNA library. The amino acid sequence of human GCNF/RTR is highly homologous to that of the mouse GCNF/RTR. The largest difference between the two homologues is a 15 amino acid deletion in the human GCNF/RTR at amino acid 47. The GCNF/RTR gene was localized on human chromosome 9. Northern blot analysis using poly(A)+ RNA from different human tissues showed that GCNF/RTR mRNA is most abundantly expressed in the testis. GCNF/RTR was also highly expressed in embryonic stem cells and embryonal carcinoma cells but repressed in its differentiated derivatives. Induction of differentiation of mouse embryonal carcinoma F9 cells and human embryonal carcinoma NTERA-2 clone Dl (NT2/D1) cells by all-trans retinoic acid was accompanied by a down-regulation of GCNF/RTR. Our observations suggest that GCNF/RTR plays a role in the control of gene expression in early embryogenesis and during spermatogenesis.
Search for other papers by A Bulotta in
Google Scholar
PubMed
Search for other papers by H Hui in
Google Scholar
PubMed
Search for other papers by E Anastasi in
Google Scholar
PubMed
Search for other papers by C Bertolotto in
Google Scholar
PubMed
Search for other papers by LG Boros in
Google Scholar
PubMed
Search for other papers by U Di Mario in
Google Scholar
PubMed
Search for other papers by R Perfetti in
Google Scholar
PubMed
The intestinal hormone glucagon-like peptide-1 (GLP-1) has been shown to promote an increase in pancreatic beta-cell mass via proliferation of islet cells and differentiation of non-insulin-secreting cells. In this study, we have characterized some of the events that lead to the differentiation of pancreatic ductal cells in response to treatment with human GLP-1. Rat pancreatic ductal (ARIP) cells were cultured in the presence of GLP-1 and analyzed for cell counting, cell cycle distribution, expression of cyclin-dependent-kinase (Cdk) inhibitors, transcription of beta-cell-specific genes, loss of ductal-like phenotype and acquisition of beta-cell-like gene expression profile. Exposure of ARIP cells to 10 nM GLP-1 induced a significant reduction in the cell replication rate and a significant decrease in the percentage of cells in S phase of the cell cycle. This was associated with an increase in the number of cells in G0-G1 phase and a reduction of cells in G2-M phase. Western blot analysis for the Cdk inhibitors, kinase inhibitor protein 1 (p27(Kip1)) and Cdk-interacting protein 1 (p21(Cip1)), demonstrated a significant increase in p27(Kip1) and p21(Cip1) levels within the first 24 h from the beginning of GLP-1 treatment. As cells slowed down their proliferation rate, GLP-1 also induced a time-dependent expression of various beta-cell-specific mRNAs. The glucose transporter GLUT-2 was the first of those factors to be expressed (24 h treatment), followed by insulin (44 h) and finally by the enzyme glucokinase (56 h). In addition, immunocytochemistry analysis showed that GLP-1 induced a time-dependent down-regulation of the ductal marker cytokeratin-20 (CK-20) and a time-dependent induction of insulin expression. Finally, GLP-1 promoted a glucose-dependent secretion of insulin, as demonstrated by HPLC and RIA analyses of the cell culture medium. The present study has demonstrated that GLP-1 induces a cell cycle re-distribution with a decrease in cell proliferation rate prior to promoting the differentiation of cells towards an endocrine-like phenotype.
Search for other papers by T Kitano in
Google Scholar
PubMed
Search for other papers by K Takamune in
Google Scholar
PubMed
Search for other papers by T Kobayashi in
Google Scholar
PubMed
Search for other papers by Y Nagahama in
Google Scholar
PubMed
Search for other papers by SI Abe in
Google Scholar
PubMed
The phenotypic sex of many teleost fishes including flounders can be experimentally altered by treating embryos or larvae with varied temperatures or sex-steroid hormones. To analyse the sex determination mechanism, especially the role of cytochrome P450 aromatase (P450arom), an enzyme that catalyses the conversion of androgens to estrogens, in temperature-dependent gonadal sex differentiation in the Japanese flounder, we generated two populations of larvae, both having XX (genetic females) but each growing up to display all phenotypic females or males, by rearing the larvae at normal (18 degrees C) or high (27 degrees C) water temperatures from days 30 to 100 after hatching respectively. The larvae (XX) were produced artificially by mating normal females (XX) with gynogenetic diploid males (XX) which had been sex-reversed to phenotypic males by 17alpha-methyltestosterone. To study the role of P450arom in sex determination in the flounder, we first isolated a P450arom cDNA containing the complete open reading frame from the ovary. RT-PCR showed that P450arom mRNA was highly expressed in the ovary and spleen but weakly in the testis and brain. Semi-quantitative analyses of P450arom mRNA in gonads during sex differentiation showed that there was no difference in the levels of P450arom mRNA between the female and male groups when the gonad was sexually indifferent (day 50 after hatching). However, after the initiation of sex differentiation (day 60), the mRNA levels increased rapidly in the female group, whereas they decreased slightly in the male group. Similarly, estradiol-17beta levels rose remarkably in the female group, yet remained constant in the male group. These results suggest that induction of sex reversal of genetically female larvae to phenotypic males by rearing them at a high water temperature caused a suppression of P450arom gene expression. Furthermore, we suggest that the maintenance of P450arom mRNA at very low levels is a prerequisite for testicular differentiation, while the increased levels are indispensable for ovarian differentiation.
Search for other papers by M. E. Hayes in
Google Scholar
PubMed
Search for other papers by D. Bayley in
Google Scholar
PubMed
Search for other papers by E. B. Mawer in
Google Scholar
PubMed
ABSTRACT
Regulation of the metabolism of [3H]25-hydroxyvitamin D3 ([3H]25-(OH)D3) in vitro to material with the characteristics of [3H]24,25-dihydroxyvitamin D3 ([3H]24,25-(OH)2D3) has been studied in the human promyelocytic cell line HL60. Synthesis of 24,25-(OH)2D3 was induced in a dose-dependent manner in cells pretreated with 0·1–100 nm 1α,25-dihydroxyvitamin D3 (1α,25-(OH)2D3) for 4 days. This treatment also inhibited cell proliferation and stimulated differentiation to a macrophage phenotype that was characterized by staining for non-specific esterase (NSE) activity. The ability to synthesize [3H]24,25-(OH)2D3 from [3H]25-(OH)D3 and the expression of NSE activity both responded to changes in concentration of 1α,25-(OH)2D3 in the culture medium in a parallel manner. Synthesis of [3H]24,25-(OH)2D3 was linear when the incubation time was between 1 and 8 h and the cell number between 1 and 12×106 cells/incubation. The optimum substrate concentration for its synthesis was 125 nm, giving an apparent Michaelis constant of 360 nm. The identity of the [3H]24,25-(OH)2D3 synthesized by these cells was confirmed by co-chromatography with authentic 24,25-(OH)2D3 on normal-phase and reverse-phase high-performance liquid chromatography systems and by its reaction to sodium-m-periodate. Cells that had been exposed to 100 nm 1α,25-(OH)2D3 for 4 days synthesized 2·17±0·07 (s.e.m.) pmol 24,25-(OH)2D3/106 cells per h. This synthesis was inhibited in a dose-dependent manner over a concentration range of 0·01–1 μm by the drug ketoconazole, an antimycotic imidazole which is a known inhibitor of certain cytochrome P-450 enzyme systems, suggesting that the HL60 25-(OH)D3-24-hydroxylase is also a P-450-dependent enzyme system.
Search for other papers by P Soultanas in
Google Scholar
PubMed
Search for other papers by P D Andrews in
Google Scholar
PubMed
Search for other papers by D R Burton in
Google Scholar
PubMed
Search for other papers by D P Hornby in
Google Scholar
PubMed
ABSTRACT
The regulation of DNA (cytosine-5) methyltransferase (DNA MeTase) enzyme activity and gene expression was examined in the monoblastoid U937 cell line induced to differentiate with either dibutyryl cyclic AMP (dbcAMP) or phorbol ester. dbcAMP treatment was found to cause the rapid (<4 h) suppression of DNA MeTase specific activity, with no DNA MeTase activity detectable after 10 h. Equally, no DNA MeTase activity was detectable in nuclear extracts of fresh peripheral blood monocytes. Using both a U937 DNA MeTase cDNA and a mouse DNA MeTase cDNA as probes, steady-state levels of DNA MeTase mRNA were found to decline sharply between 4 and 15 h after dbcAMP treatment. No DNA MeTase mRNA was detectable after 20 h of dbcAMP treatment. Nuclear run-on analysis showed there to be only a small (40%) suppression of DNA MeTase gene transcription in cells treated with dbcAMP for 24 h, implying a role for post-transcriptional processes in the regulation of DNA MeTase mRNA levels. The observed decline in DNA MeTase activity/mRNA levels appeared to precede the dbcAMP-induced arrest in DNA replication, as judged by the incorporation of tritiated thymidine into DNA.
In contrast to the effect of dbcAMP, treatment of U937 cells with the phorbol ester 12-O-tetradecanoyl phorbol-13-acetate (TPA) led to an overall stimulation of DNA MeTase specific activity. The TPA response was found to be complex and broadly consisted of an early (0–15 h) burst of DNA MeTase activity followed by a more gradual sustained increase in DNA MeTase activity after prolonged (16–40 h) TPA treatment. The early phase of high DNA MeTase activity was not mirrored by an increase in steady-state levels of DNA MeTase mRNA, as judged by Northern blot analysis. However, a substantial induction of DNA MeTase mRNA levels was observed after 20–24 h of TPA treatment. Nuclear run-on analysis showed this not to be due to any significant increase in DNA MeTase gene transcription. The observed increases in DNA MeTase activity/mRNA levels were observed whilst cells were undergoing deproliferation. Interestingly, the addition of TPA and more physiological protein kinase C (PKC) activators, such as diacylglycerol and phosphatidylserine, to DNA MeTase-enriched nuclear extracts generated a 4·5-fold and a 1·5-fold increase in DNA MeTase specific activity respectively. The TPA-induced stimulation of DNA MeTase activity could be inhibited by the PKC inhibitor H-9, implicating a role for PKC in the regulation of DNA MeTase activity in vivo.
Search for other papers by P Diel in
Google Scholar
PubMed
Search for other papers by D Baadners in
Google Scholar
PubMed
Search for other papers by K Schlüpmann in
Google Scholar
PubMed
Search for other papers by M Velders in
Google Scholar
PubMed
Search for other papers by J P Schwarz in
Google Scholar
PubMed
appears in full here: Figure 7 The effect of dihydrotestosterone (DHT) on Pax7 expression during C2C12 cell differentiation. (A) Time-dependent analysis of Pax7 protein expression. After 2 (d2), 4 (d4), 6 (d6), and 8 (d8) days, the cells were fixed and
Inserm U982, University of Rouen, Department of Anesthesiology and Critical Care, Research Center in Molecular Endocrinology, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation
Inserm U982, University of Rouen, Department of Anesthesiology and Critical Care, Research Center in Molecular Endocrinology, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation
Search for other papers by V Compère in
Google Scholar
PubMed
Inserm U982, University of Rouen, Department of Anesthesiology and Critical Care, Research Center in Molecular Endocrinology, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation
Search for other papers by D Lanfray in
Google Scholar
PubMed
Inserm U982, University of Rouen, Department of Anesthesiology and Critical Care, Research Center in Molecular Endocrinology, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation
Search for other papers by H Castel in
Google Scholar
PubMed
Inserm U982, University of Rouen, Department of Anesthesiology and Critical Care, Research Center in Molecular Endocrinology, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation
Search for other papers by F Morin in
Google Scholar
PubMed
Inserm U982, University of Rouen, Department of Anesthesiology and Critical Care, Research Center in Molecular Endocrinology, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation
Search for other papers by J Leprince in
Google Scholar
PubMed
Search for other papers by B Dureuil in
Google Scholar
PubMed
Inserm U982, University of Rouen, Department of Anesthesiology and Critical Care, Research Center in Molecular Endocrinology, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation
Search for other papers by H Vaudry in
Google Scholar
PubMed
Search for other papers by G Pelletier in
Google Scholar
PubMed
Inserm U982, University of Rouen, Department of Anesthesiology and Critical Care, Research Center in Molecular Endocrinology, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation
Search for other papers by M C Tonon in
Google Scholar
PubMed
In the central nervous system of mammals, the gene encoding diazepam-binding inhibitor (DBI) is exclusively expressed in glial cells. Previous studies have shown that central administration of a DBI processing product, the octadecaneuropeptide ODN, causes a marked inhibition of food consumption in rodents. Paradoxically, however, the effect of food restriction on DBI gene expression has never been investigated. Here, we show that in mice, acute fasting dramatically reduces DBI mRNA levels in the hypothalamus and the ependyma bordering the third and lateral ventricles. I.p. injection of insulin, but not of leptin, selectively stimulated DBI expression in the lateral ventricle area. These data support the notion that glial cells, through the production of endozepines, may relay peripheral signals to neurons involved in the central regulation of energy homeostasis.
Search for other papers by H Lejeune in
Google Scholar
PubMed
Search for other papers by R Habert in
Google Scholar
PubMed
Search for other papers by JM Saez in
Google Scholar
PubMed
Centro de Biología Molecular Severo Ochoa UAM-CSIC, Facultad de Ciencias, Universidad Autónoma, 28049 Madrid, Spain
Search for other papers by R Serrano in
Google Scholar
PubMed
Centro de Biología Molecular Severo Ochoa UAM-CSIC, Facultad de Ciencias, Universidad Autónoma, 28049 Madrid, Spain
Search for other papers by M Villar in
Google Scholar
PubMed
Centro de Biología Molecular Severo Ochoa UAM-CSIC, Facultad de Ciencias, Universidad Autónoma, 28049 Madrid, Spain
Search for other papers by C Martínez in
Google Scholar
PubMed
Centro de Biología Molecular Severo Ochoa UAM-CSIC, Facultad de Ciencias, Universidad Autónoma, 28049 Madrid, Spain
Search for other papers by J M Carrascosa in
Google Scholar
PubMed
Centro de Biología Molecular Severo Ochoa UAM-CSIC, Facultad de Ciencias, Universidad Autónoma, 28049 Madrid, Spain
Search for other papers by N Gallardo in
Google Scholar
PubMed
Centro de Biología Molecular Severo Ochoa UAM-CSIC, Facultad de Ciencias, Universidad Autónoma, 28049 Madrid, Spain
Search for other papers by A Andrés in
Google Scholar
PubMed
regulated by stage of development and by cell differentiation, with IR-A being the predominant IR isoform in fetal tissues and cancer cells ( Frasca et al. 1999 ). The two IRs have been reported to exhibit distinct functional properties. IR-A shows
Search for other papers by Jérémy Pasquier in
Google Scholar
PubMed
Search for other papers by Nédia Kamech in
Google Scholar
PubMed
Search for other papers by Anne-Gaëlle Lafont in
Google Scholar
PubMed
Search for other papers by Hubert Vaudry in
Google Scholar
PubMed
Search for other papers by Karine Rousseau in
Google Scholar
PubMed
Search for other papers by Sylvie Dufour in
Google Scholar
PubMed
Following the discovery of kisspeptin (Kiss) and its receptor (GPR54 or KissR) in mammals, phylogenetic studies revealed up to three Kiss and four KissR paralogous genes in other vertebrates. The multiplicity of Kiss and KissR types in vertebrates probably originated from the two rounds of whole-genome duplication (1R and 2R) that occurred in early vertebrates. This review examines compelling recent advances on molecular diversity and phylogenetic evolution of vertebrate Kiss and KissR. It also addresses, from an evolutionary point of view, the issues of the structure–activity relationships and interaction of Kiss with KissR and of their signaling pathways. Independent gene losses, during vertebrate evolution, have shaped the repertoire of Kiss and KissR in the extant vertebrate species. In particular, there is no conserved combination of a given Kiss type with a KissR type, across vertebrate evolution. The striking conservation of the biologically active ten-amino-acid C-terminal sequence of all vertebrate kisspeptins, probably allowed this evolutionary flexibility of Kiss/KissR pairs. KissR mutations, responsible for hypogonadotropic hypogonadism in humans, mostly occurred at highly conserved amino acid positions among vertebrate KissR. This further highlights the key role of these amino acids in KissR function. In contrast, less conserved KissR regions, notably in the intracellular C-terminal domain, may account for differential intracellular signaling pathways between vertebrate KissR. Cross talk between evolutionary and biomedical studies should contribute to further understanding of the Kiss/KissR structure–activity relationships and biological functions.
